Noveris Health Sciences Inc
Open
–
Prev. Close
–
High
–
Low
–
Market Snapshot
$128.55M
41.0
1.85
3
Noveris Health Sciences, Inc. is a biotechnology company, which engages in the research, drug development, and clinical trials of psilocybin products. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2014-08-18. The firm focuses on the next generation of psychedelic medicine by creating innovative compounds with unmatched therapeutic potential through its clinical trial efforts with scientific and regulatory expertise.
Noveris Health Sciences, Inc. is a biotechnology company, which engages in the research, drug development, and clinical trials of psilocybin products. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2014-08-18. The firm focuses on the next generation of psychedelic medicine by creating innovative compounds with unmatched therapeutic potential through its clinical trial efforts with scientific and regulatory expertise.
Recently from Cashu
Couldn't load Cashu news
Something went wrong. Try refreshing the page.